SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-23-023415
Filing Date
2023-03-28
Accepted
2023-03-28 08:30:10
Documents
14
Period of Report
2023-03-27
Items
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea175865-8k_dominari.htm   iXBRL 8-K 31035
2 AMENDED AND RESTATED MEMBERSHIP INTEREST PURCHASE AGREEMENT ea175865ex10-1_dominari.htm EX-10.1 159751
3 PRESS RELEASE OF DOMINARI HOLDINGS INC. ANNOUNCING THE CLOSING OF ITS ACQUISITIO ea175865ex99-1_dominari.htm EX-99.1 6405
  Complete submission text file 0001213900-23-023415.txt   410324

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE domh-20230327.xsd EX-101.SCH 3239
5 XBRL LABEL FILE domh-20230327_lab.xml EX-101.LAB 34240
6 XBRL PRESENTATION FILE domh-20230327_pre.xml EX-101.PRE 22367
8 EXTRACTED XBRL INSTANCE DOCUMENT ea175865-8k_dominari_htm.xml XML 3601
Mailing Address ONE ROCKEFELLER PLAZA, 11TH FLOOR NEW YORK NY 10020
Business Address ONE ROCKEFELLER PLAZA, 11TH FLOOR NEW YORK NY 10020 347-321-7646
Dominari Holdings Inc. (Filer) CIK: 0000012239 (see all company filings)

IRS No.: 520849320 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-05576 | Film No.: 23766296
SIC: 2834 Pharmaceutical Preparations